Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells

被引:8
作者
Kato, Y [1 ]
Yamashita, T [1 ]
Ishikawa, M [1 ]
机构
[1] Asahikawa Med Coll, Dept Obstet & Gynecol, Asahikawa, Hokkaido 0788510, Japan
关键词
cervical cancer; MMP-2; MMP-9; MMP inhibitor; real-time PCR; zymography; invasion assay;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Constitutive overexpression of matrix metalloproteinases (MMPs) is frequently observed in malignant tumors. MMPs are a family of zinc endopeptidases consisting of at least 20 different members. In particular, MMP-2 and MMP-9 are reported to be closely associated with invasion and metastasis in several cancers. We investigated whether expression of MMP-2 and MMP-9 is associated with invasion ability of seven cervical cancer cells by administration of o-phenanthroline as MMP inhibitor. In two cell lines, Siha and Caski. MMP-2 mRNA and protein were expressed at high levels. After treatment with o-phenanthroline, the rate of invasion in these two cell lines was significantly decreased. In contrast, in the other two cell lines, HT-3 and Caski, high levels of MMP-9 mRNA and protein were expressed but there was no decrease in the rate of invasion in these cells after treatment with o-phenanthroline. The data suggest that expression level of MMP-2 mRNA may regulate with invasion ability of cervical cancer.
引用
收藏
页码:565 / 569
页数:5
相关论文
共 34 条
[1]  
ALBINI A, 1987, CANCER RES, V47, P3239
[2]   MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts [J].
Boyd, RS ;
Balkwill, FR .
BRITISH JOURNAL OF CANCER, 1999, 80 (3-4) :315-321
[3]  
Bramhall SR, 1997, INT J PANCREATOL, V21, P1
[4]   ACTIVITY OF TYPE-IV COLLAGENASES IN BENIGN AND MALIGNANT BREAST DISEASE [J].
DAVIES, B ;
MILES, DW ;
HAPPERFIELD, LC ;
NAYLOR, MS ;
BOBROW, LG ;
RUBENS, RD ;
BALKWILL, FR .
BRITISH JOURNAL OF CANCER, 1993, 67 (05) :1126-1131
[5]  
DAVIES B, 1993, CANCER RES, V53, P5365
[6]  
Eccles SA, 1996, CANCER RES, V56, P2815
[7]  
Edwards DR, 1996, INT J OBESITY, V20, P9
[8]   Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas [J].
Forsyth, PA ;
Wong, H ;
Laing, TD ;
Rewcastle, NB ;
Morris, DG ;
Muzik, H ;
Leco, KJ ;
Johnston, RN ;
Brasher, PMA ;
Sutherland, G ;
Edwards, DR .
BRITISH JOURNAL OF CANCER, 1999, 79 (11-12) :1828-1835
[9]   Development of matrix metalloproteinase inhibitors in cancer therapy [J].
Hidalgo, M ;
Eckhardt, SG .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (03) :178-193
[10]  
Kenagy RD, 1997, CIRCULATION, V96, P3555